Nexus Surgical And Medicare Ltd

Nexus Surgical And Medicare Ltd

$NEXUSSURGLOther Financial ServicesBSE

Nexus Surgical And Medicare Ltd (NEXUSSURGL) last traded at ₹19, a market capitalisation of ₹10.4 crore, on a P/E of 13.3. Over the past 52 weeks the stock has ranged between ₹13.3 and ₹25.5. Nexus Surgical And Medicare Ltd last reported results for the quarter ended Jun 2026, with sales of ₹2.55 crore and net profit of ₹0.2 crore. Figures are as of 25 Aug 2026 and are not real time.

Nexus Surgical And Medicare Ltd share price and key metrics

Current price
₹19
Market cap
₹10.4 cr
Stock P/E
13.3
Book value
₹3.29
ROE
51.8%
ROCE
69.2%
Dividend yield
0.00%
52w high / low
25.5/13.3

Metrics as of 25 Aug 2026. Not real time.

Nexus Surgical And Medicare Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹2.55 cr, up 47.4% from ₹1.73 cr a year earlier. Net profit was ₹0.2 cr, up 33.3% year on year.

Nexus Surgical And Medicare Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales0.991.481.481.731.172.932.052.55
Expenses0.711.331.371.530.942.711.752.31
Operating profit0.280.150.110.20.230.220.30.24
OPM %28.28%10.14%7.43%11.56%19.66%7.51%14.63%9.41%
Other income000.01000.010.020.03
Interest00000000
Depreciation00000000
Profit before tax0.280.150.120.20.230.230.320.27
Tax %25.00%26.67%25.00%25.00%26.09%26.09%25.00%25.93%
Net profit0.210.110.090.150.170.170.240.2
EPS (₹)0.380.200.160.270.310.310.440.37

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Nexus Surgical And Medicare Ltd annual results

Nexus Surgical And Medicare Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales3.742.41.553.475.727.878.7
Operating profit0.160.370.220.270.670.960.99
OPM %4.28%15.42%14.19%7.78%11.71%12.20%11.38%
Net profit0.150.290.170.210.50.740.78
EPS (₹)0.270.530.310.380.911.351.43

TTM is the trailing twelve months to the most recent quarter.

Nexus Surgical And Medicare Ltd growth and returns

Compounded Sales Growth
10 Years
37%
5 Years
16%
3 Years
72%
TTM
53%
Compounded Profit Growth
10 Years
31%
5 Years
38%
3 Years
63%
TTM
39%
Stock Price CAGR
10 Years
-10%
5 Years
46%
3 Years
27%
1 Year
24%
Return on Equity
10 Years
%
5 Years
64%
3 Years
54%
Last Year
52%

Nexus Surgical And Medicare Ltd shareholding pattern

Promoters held 18.73% at Jun 2026, broadly unchanged since Jun 2025.

Nexus Surgical And Medicare Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters18.73%18.73%18.73%18.73%18.73%18.73%18.73%18.73%
Public81.27%81.27%81.26%81.26%81.27%81.28%81.28%81.27%
No. of shareholders5,1025,8666,0246,1376,0485,9975,8585,743

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

Nexus Surgical And Medicare Ltd corporate filings

  • Submission of Unaudited Quarterly Financial Results of the Company for the quarter ended 30th June, 2026Resulthigh impact
    Filing PDF

    Cruxal's analysis: Nexus Surgical and Medicare Limited reported a strong performance for the quarter ended…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Nexus Surgical And Medicare Ltd

Cruxal reads every Nexus Surgical And Medicare Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.

Nexus Surgical And Medicare Ltd (NEXUSSURGL) Results, Financials & Share Price | Cruxal